NEW YORK ( TheStreet) -- CHANGE IN RATINGS, EPS

Accretive Health ( AH) upgraded at Goldman from Neutral to Buy. $31 price target. Stock is attractive, following a 38% selloff.

Acme Packet ( APKT) numbers reduced at Goldman. Shares of APKT now seen reaching $35, according to Goldman Sachs. Estimates also cut, given slower expected revenue growth. Neutral rating.

Alaska Air ( ALK) numbers raised at Citigroup. Shares of ALK now seen reaching $81. Estimates also increased leading fundamentals and attractive valuation. Buy rating.

Alaska Air estimates raised at UBS through 2012. Solid 3Q and 2012 cost guidance positive. Maintain $81 price target and Buy rating.

Alexion Pharmaceuticals ( ALXN) numbers upped at Jefferies. ALXN estimates were boosted through 2012. Company is seeing higher Soliris sales and cutting costs. Hold rating and new $58 price target.

Alexion Pharmaceutical estimates, target raised at UBS. Shares of ALXN now seen reaching $70. Estimates also increased on aHUS and margins. Neutral rating.

Alliance Data Systems ( ADS) upgraded to buy at TheStreet Ratings.

Altera ( ALTR) estimates, target reduced at Jefferies. ALTR estimates were cut through 2012. Inventories are falling. Buy rating and new $43 price target.

Altera estimates, target cut at UBS. Shares of ALTR now seen reaching $44.50. Estimates also lowered as weak macro slows secular growth. Buy rating.

Associated Banc-Corp ( ASBC) numbers lowered at Jefferies. Shares of ASBC now seen reaching $11. Estimates also cut, given reduced net interest income expectations. Buy rating.

AT&T ( T) estimates lowered at Citigroup through 2012. Reflects an elevation in dilution from a rapid adoption of Smartphones. Maintain $32 price target and Buy rating.

AutoNation ( AN) estimates, target raised at Goldman. Shares of AN now seen reaching $34. Estimates also increased, given better realized operating margin. Sell rating.

AutoNation estimates lowered at UBS through 2011. Margins tailwinds end post Q3. Maintain $30 price target and Sell rating.

Baxter ( BAX) estimates, target reduced at Goldman. BAX estimates were cut through 2014. Lower sales are hurting margins. Buy rating and new $66 price target.

Blackstone ( BX) estimates adjusted at Citigroup through 2012. Reflects the 3Q shortfall, but also stronger long term asset gathering outlook. Maintain $18 price target and Buy rating.

Capital One ( COF) numbers increased at Goldman through 2013. Higher revenue is driving margin expansion. Neutral rating and new $51 price target.

Chipotle Mexican Grill ( CMG) estimates lowered at UBS through 2012. Sales beat, margins miss, view unchanged. Maintain $345 price target and Neutral rating.

Chubb ( CB) estimates lowered at UBS through 2012. Guidance revised downward based on heavy 3Q cat losses. Maintain $70 price target and Buy rating.

Cooper Industriesv ( CBE) numbers boosted at Goldman. Shares of CBE now seen reaching $55. Estimates also upped, given better margin visibility. Neutral rating.

Covance ( CVD) estimates, target reduced at Jefferies. CVD estimates were cut through 2012. Company still has excess capacity. Hold rating and new $53 price target.

Covanta ( CVA) upgraded at Ardour from Accumulate to Buy. $21 price target. Company has a strong earnings base and the stock is attractive, following a recent pullback.

Danaher ( DHR) estimates, target upped at Goldman. DHR estimates were boosted through 2013. Company is realizing higher margins and paying lower interest expense.

Eldorado Gold ( EGO) upgraded at Canaccord from Hold to Buy. $21.50 price target. Enhanced production profile and dividend policy leads to bump in valuation.

Eli Lilly ( LLY) estimates cut at Credit Suisse through 2013. Company will likely not cut costs as quickly as expected. Neutral rating and $39 price target.

Flextronics ( FLEX) estimates, target raised at Citigroup. Shares of FLEX now seen reaching $7. Estimates also increased on a more optimistic margin outlook. Neutral rating.

Flextronics estimates, target boosted at Goldman. Shares of FLEX now seen reaching $5.25. Estimates also upped, given higher sales and lower interest expense. Sell rating.

Freescale ( FSL) estimates, target cut at Credit Suisse. FSL estimates were reduced through 2012. Cellular business remains weak. Outperform rating and new $18 price target.

Hershey ( HSY) estimates, target boosted at Credit Suisse. Shares of HSY now seen reaching $70. Estimates also upped, as the company has solid pricing power. Outperform rating.

Huntington Bancshares ( HBAN) numbers cut at Jefferies. HBAN estimates were reduced through 2012. Company's costs remain high. Buy rating and new $6 price target.

Huntington Bancshares ( HBAN) downgraded at Oppenheimer from Outperform to Perform. Thesis played out with few near term catalysts.

Ingersoll-Rand ( IR) downgraded to hold at TheStreet Ratings.

Ingersoll-Rand cut from Focus List at Credit Suisse. Valuation call, based on a $41 price target.

Ingersoll-Rand numbers lowered at Jefferies. Shares of IR now seen reaching $38. Estimates also cut, given reduced residential expectations. Buy rating.

Keycorp ( KEY) estimates, target increased at Jefferies. KEY estimates were raised through 2012. Operating trends are improving. Hold rating and new $7.50 price target.

Laboratory Corp. ( LH) numbers lowered at Credit Suisse. Shares of LH now seen reaching $91. Estimates also cut, given slower underlying growth trends. Neutral rating.

Microsoft ( MSFT) estimates lowered at Goldman through 2014. Company is seeing higher operating costs. Neutral rating $29 price target.

Microsoft estimates lowered at UBS through 2013 on Skype and revenue mix shift, UBS said. Maintain $33 price target and Buy rating.

National Penn Bancshares ( NPBC) downgraded at Guggenheim from Buy to Neutral. $8 price target. Current premium valuation reflects earnings profile.

Newfield Exploration ( NFX) numbers cut at Jefferies. Shares of NFX now seen reaching $44. Estimates also reduced, as the company is seeing limited growth opportunities. Hold rating.

Noble ( NE) estimates, target cut at Credit Suisse. Shares of NE now seen reaching $49. Estimates also reduced, as the company is seeing higher unanticipated downtime. Outperform rating.

Noble Corporation estimates lowered at UBS through 2012. Reflects below the line items, including higher SG&A. Maintain $42 price target and Buy rating.

Nucor ( NUE) estimates, target cut at Jefferies. Shares of NUE now seen reaching $45. Estimates also reduced, given lower expected steel demand.

Pall ( PLL) added to Focus List at Credit Suisse. $61 price target. Company is cutting costs and can generate solid near-term growth.

Penn National Gaming ( PENN) downgraded at Brean Murray from Buy to Hold. 3Q trends remain solid, but note of caution on growth trajectory will likely depress valuation.

Philip Morris ( PM) numbers raised at Morgan Stanley. Shares of PM now seen reaching $78. Estimates also increased, as the company is posting solid growth across the board. Overweight rating.

Raymond James ( RJF) numbers increased at Goldman. RJF estimates were raised through 2013. Investment banking remains strong. Neutral rating and new $32 price target.

SanDisk ( SNDK) estimates adjusted at UBS through 2012. Upside Q3 results with solid demand outlook heading into 2012. Buy rating.

Seagate Technology ( STX) upgraded at Baird from Neutral to Outperform. $17 price target. Company can take market share in the coming quarters.

Southwest ( LUV) numbers raised at UBS. Shares of LUV now seen reaching $10. Estimates also increased on top line performance. Maintain Neutral rating.

TCF Financial ( TCB) upgraded at Oppenheimer from Perform to Outperform. Pressure on fees now taking a backseat.

TIBCO Software ( TIBX) rated new Buy at Think. $32 price target. Increasing adoption of mobility driving business.

UHS ( UHS) estimates lowered at UBS through 2012. Volumes remain weak despite easier comps. Maintain $55 price target and Buy rating.

Union Pacific ( UNP) estimates raised at Citigroup through 2012. Strong quarter in a challenging market, incrementals accelerate. Maintain $106 price target and Buy rating.

Union Pacific numbers raised at Credit Suisse. Shares of UNP now seen reaching $120. Estimates also increased, given higher realized yields. Outperform rating.

Walt Disney ( DIS) numbers reduced at Morgan Stanley. DIS estimates were cut through 2013. Company lowered its guidance. Overweight rating and new $40 price target.

Wynn Resorts ( WYNN) upgraded at BMO from Market Perform to Outperform. $167 price target. Earnings, cash flow, Cotai, all catalysts for valuation.

Related links:


This article was written by a staff member of TheStreet.

If you liked this article you might like

Jim Cramer: Round Up the Usual Suspects

Jim Cramer: Round Up the Usual Suspects

It Wasn't Just the Dollar

It Wasn't Just the Dollar

The President Must Show 'America First' Isn't 'America Alone': Market Recon

The President Must Show 'America First' Isn't 'America Alone': Market Recon

Hormel Foods, Baidu.com, Palo Alto Networks: 'Mad Money' Lightning Round

Hormel Foods, Baidu.com, Palo Alto Networks: 'Mad Money' Lightning Round

Investors Can't Get Enough: Cramer's 'Mad Money' Recap (Thursday 1/18/18)

Investors Can't Get Enough: Cramer's 'Mad Money' Recap (Thursday 1/18/18)